Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Haya Ascher-Svanum

Characteristics of Patients Misdiagnosed With Alzheimer’s Disease and Their Medication Use: An Analysis of the NACC-UDS Database

BMC Geriatrics

Gerontology

Geriatrics

2013

English

The Longitudinal Interplay Between Negative and Positive Symptom Trajectories in Patients Under Antipsychotic Treatment: A Post Hoc Analysis of Data From a Randomized, 1-Year Pragmatic Trial

English

Change in Level of Productivity in the Treatment of Schizophrenia With Olanzapine or Other Antipsychotics

English

Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes

Clinical Therapeutics

Pharmacology

2015

English

Comparison of Patients Undergoing Switching Versus Augmentation of Antipsychotic Medications During Treatment for Schizophrenia

Neuropsychiatric Disease and Treatment

Psychiatry

Mental Health

Biological Psychiatry

2012

English

Orally Disintegrating Olanzapine Review: Effectiveness, Patient Preference, Adherence, and Other Properties

Patient Preference and Adherence

English

Treatment Discontinuation and Clinical Outcomes in the 1-Year Naturalistic Treatment of Patients With Schizophrenia at Risk of Treatment Nonadherence

Patient Preference and Adherence

English

Treatment-Completion Rates With Olanzapine Long-Acting Injection Versus Risperidone Long-Acting Injection in a 12-Month, Open-Label Treatment of Schizophrenia: Indirect, Exploratory Comparisons

International Journal of General Medicine

Medicine

2012

English

Costs of Treating Patients With Schizophrenia Who Have Illness-Related Crisis Events

English

Maintenance of Response With Atypical Antipsychotics in the Treatment of Schizophrenia: A Post-Hoc Analysis of 5 Double-Blind, Randomized Clinical Trials

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Haya Ascher-Svanum

Characteristics of Patients Misdiagnosed With Alzheimer’s Disease and Their Medication Use: An Analysis of the NACC-UDS Database

The Longitudinal Interplay Between Negative and Positive Symptom Trajectories in Patients Under Antipsychotic Treatment: A Post Hoc Analysis of Data From a Randomized, 1-Year Pragmatic Trial

Change in Level of Productivity in the Treatment of Schizophrenia With Olanzapine or Other Antipsychotics

Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes

Comparison of Patients Undergoing Switching Versus Augmentation of Antipsychotic Medications During Treatment for Schizophrenia

Orally Disintegrating Olanzapine Review: Effectiveness, Patient Preference, Adherence, and Other Properties

Treatment Discontinuation and Clinical Outcomes in the 1-Year Naturalistic Treatment of Patients With Schizophrenia at Risk of Treatment Nonadherence

Treatment-Completion Rates With Olanzapine Long-Acting Injection Versus Risperidone Long-Acting Injection in a 12-Month, Open-Label Treatment of Schizophrenia: Indirect, Exploratory Comparisons

Costs of Treating Patients With Schizophrenia Who Have Illness-Related Crisis Events

Maintenance of Response With Atypical Antipsychotics in the Treatment of Schizophrenia: A Post-Hoc Analysis of 5 Double-Blind, Randomized Clinical Trials